Results 31 to 40 of about 18,695,385 (300)

Insulin infusion sets associated with adverse events: strategies for improved diabetes education

Frontiers in Medicine, 2023
IntroductionInsulin Infusion Sets (IIS) play a crucial role in ensuring the safe delivery of insulin through a Continuous Subcutaneous Insulin Infusion (CSII) for individuals with Type 1 Diabetes (T1D). Recent advancements in therapy have highlighted the
Ana Lucia Domingues Neves, Luiz Eduardo Galvão Martins, Mônica Andrade Lima Gabbay, Mônica Andrade Lima Gabbay, Paula Pascali, Tiago de Oliveira, Aldo Martinazzo, Sérgio Atala Dib, Sérgio Atala Dib, Dulce Elena Casarini, Sebastião Vagner Aredes, Fernanda Silva Tenorio, Tatiana Sousa Cunha   +12 more
doaj   +1 more source

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21 [PDF]

, 2009
OBJECTIVE—Fibroblast growth factor (FGF)-21 improves insulin sensitivity and lipid metabolism in obese or diabetic animal models, while human studies revealed increased FGF-21 levels in obesity and type 2 diabetes.
Pfeiffer, Andreas F. H., Meinus, S., Andres, Janin, Biedasek, Katrin, Biedasek, K., Spranger, J., Mai, K., Reinecke, F., Spuler, S., Pfeiffer, A.F., Moehlig, M., Sabath, Markus, Clemenz, M., Mai, Knut, Bobbert, T., Meinus, Sabine, Spranger, Joachim, Reinecke, Franziska, Weickert, Martin O., Bobbert, Thomas, Weicht, J., Möhlig, Matthias, Andres, J., Weicht, Jessica, Kintscher, U., Spuler, Simone, Clemenz, Markus, Sabath, M., Weickert, M.O., Kintscher, Ulrich   +29 more
core   +1 more source

Development and validation of an instrument (CSII – Brazil) to assess users’ conceptual and procedural knowledge of continuous subcutaneous infusion systems

Archives of Endocrinology and Metabolism, 2020
Objective: To develop, adapt and validate an instrument named “CSII – Brazil” to assess users’ conceptual and procedural knowledge of continuous subcutaneous insulin infusion systems. Materials and methods: Methodological and exploratory study developed
Camilla Magalhães de Oliveira Amaral, Carla Ferraz de Oliveira Borges, Adriana Silvina Pagano, Aleida Nazareth Soares, Gabriela Franco Mourão, Janice Sepúlveda Reis   +5 more
doaj   +1 more source

Report of high insulin requirements in pediatric critically ill patients with COVID-19. Experience with continuous remote glucose monitoring

Revista de la Sociedad Argentina de Diabetes, 2021
Critically ill patients with COVID-19 suffer from sustained hyperglycemia that is difficult to manage. Added to this is the challenge of minimizing exposure to contagion.
Andrea Gabriela Krochik, Mariana Prieto, Carolina Martínez Mateu, Consuelo Barcala, Rosario Gallagher, Silvia Filippini, Delfina Arambarri, Leandro Mendoza, Nicolás Rosales, Hernán De Battista, Ricardo Sánchez Peña, Fabricio Garelli   +11 more
doaj   +1 more source

Development and application of insulin infusion profiles for therapy of type I diabetics with portable insulin infusion systems

Life support systems : the journal of the European Society for Artificial Organs, 1985
The metabolism of insuIin-dependent diabetics (lDDs) cannot always be normalized by the conventional subcutaneous insulin regimen that usually provides only two Injections of reguIar and intermediate-acting insulin per day, but glucose-controlled intravenous insuIin infusion ensures almost normal glycaemia all day long.
Schulz, Gerhard, Strack, Thomas, Beyer, Jürgen, Krause, Ulrich, Cordes, Uwe, Weber, Thomas, Nagel, Joachim H., Beutelspacher, Friedrich   +7 more
openaire   +4 more sources

Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway

Cell Communication and Signaling, 2019
Background Ghrelin modulates many physiological processes. However, the effects of intestinal ghrelin on hepatic glucose production (HGP) are still unclear.
Yao Lin, Zerong Liang, Liping He, Mengliu Yang, Dongfang Liu, Harvest F. Gu, Hua Liu, Zhiming Zhu, Hongting Zheng, Ling Li, Gangyi Yang   +10 more
doaj   +1 more source

Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes

Sensors, 2021
Technology advances have made possible improvements such as Continuous Glucose Monitors, giving the patient a glucose reading every few minutes, or insulin pumps, allowing more personalized therapies.
Jesús Berián, Ignacio Bravo, Alfredo Gardel-Vicente, José-Luis Lázaro-Galilea, Mercedes Rigla   +4 more
doaj   +1 more source

Insulin resistance syndrome in a patient with limited cutaneous systemic sclerosis and type 2 diabetes and its response to plasma exchange, immunosuppression, and the Minimed® 780G continuous subcutaneous insulin infusion hybrid system

Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Introduction: Type B insulin resistance syndrome (TBIRS) is an immune-mediated disorder characterized by severe acanthosis nigricans and difficult-to-control diabetes mellitus. This condition represents a complex clinical challenge.
Fabio Nelson Figueroa Agudelo, Víctor Manuel Blanco Pico, Andrés Octavio García Trujillo, Jorge Wilmar Tejada Marín, Karen Milena Feriz Bonelo, Guillermo Edinson Guzmán Gómez, Carlos Alberto Cañas   +6 more
doaj   +1 more source

Intravenous insulin infusion system to determine insulin regimen in diabetics.

The Tohoku Journal of Experimental Medicine, 1988
An algorithm for insulin infusion system to control blood glucose was derived from results of intravenous (i.v.) insulin infusion performed on 10 diabetics. I.v. insulin infusion was done on 14 diabetics for 24 hr using the algorithm, and blood glucose was controlled within the proper range in all cases; mean blood glucose was 130 +/- 42 mg/100 ml ...
ITO, MASAAKI, SATO, TOKUTARO, SAITO, TUYOSHI, KOKUBUN, MASARU, INOUE, MICHIKO, SAITO, KAZUKO, YOSHINAGA, KAORU   +6 more
openaire   +3 more sources

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila

FEBS Letters, EarlyView.
Animals must match their growth rate to available nutrients. We show that in Drosophila larvae, the nutrient‐sensing TOR kinase controls growth by regulating levels of TFAM, a key regulator of mitochondrial function, in the adipose tissue. When nutrients are abundant, high TOR activity suppresses TFAM, lowering mitochondrial bioenergetic activity and ...
Shrivani Sriskanthadevan‐Pirahas, Shahoon Khan, Abhishek Sharma, Byoungchun Lee, Savraj S. Grewal   +4 more
wiley   +1 more source